Edwards Lifesciences (EW) Short Interest Ratio & Short Volume $74.81 +0.88 (+1.19%) (As of 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Edwards Lifesciences Short Interest DataEdwards Lifesciences (EW) has a short interest of 8.58 million shares, representing 1.48% of the float (the number of shares available for trading by the public). This marks a 24.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 4.73 million shares to cover all short positions.Current Short Interest8,580,000 sharesPrevious Short Interest6,870,000 sharesChange Vs. Previous Month+24.89%Dollar Volume Sold Short$612.18 millionShort Interest Ratio1.5 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares589,800,000 sharesFloat Size579,780,000 sharesShort Percent of Float1.48%Today's Trading Volume14,033,775 sharesAverage Trading Volume4,725,668 sharesToday's Volume Vs. Average297% Short Selling Edwards Lifesciences? Sign up to receive the latest short interest report for Edwards Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEW Short Interest Over TimeEW Days to Cover Over TimeEW Percentage of Float Shorted Over Time Ad Porter & CompanyWhat Joe Biden got rightAnyone with a brain knows Joe Biden failed this country from day one. But, even I must admit there is one thing the Biden administration did right. I call this tech, “The AI Keystone.” It’s the number-one way to capitalize on the trillion-dollar artificial intelligence market.check out my new report. Edwards Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20248,580,000 shares $612.18 million +24.9%1.5%1.5 $71.35 11/15/20246,870,000 shares $465.51 million -10.8%1.2%1.1 $67.76 10/31/20247,700,000 shares $516.05 million -6.3%1.3%1.3 $67.02 10/15/20248,220,000 shares $566.36 million -14.5%1.4%1.2 $68.90 9/30/20249,610,000 shares $634.16 million -15.6%1.6%1.4 $65.99 9/15/202411,380,000 shares $779.76 million +81.8%1.9%1.8 $68.52 Get the Latest News and Ratings for EW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/20246,260,000 shares $437.95 million -1.3%1.1%1.1 $69.96 8/15/20246,340,000 shares $432.01 million +3.9%1.1%1.3 $68.14 7/31/20246,100,000 shares $384.54 million -20.8%1.0%1.4 $63.04 7/15/20247,700,000 shares $689.15 million -15.8%1.3%2.7 $89.50 6/30/20249,140,000 shares $844.26 million +11.6%1.5%3.3 $92.37 6/15/20248,190,000 shares $714.91 million -1.2%1.4%3 $87.29 5/31/20248,290,000 shares $720.94 million +3.6%1.4%2.9 $86.97 5/15/20248,000,000 shares $721.28 million -16.9%1.4%2.5 $90.16 4/30/20249,630,000 shares $815.47 million +30.5%1.6%2.7 $84.68 4/15/20247,380,000 shares $658.30 million -28.9%1.3%1.9 $89.20 3/31/202410,380,000 shares $991.91 million -0.7%1.8%2.6 $95.56 3/15/202410,450,000 shares $964.64 million +23.8%1.8%2.7 $92.31 2/29/20248,440,000 shares $716.30 million -16.4%1.4%1.9 $84.87 2/15/202410,090,000 shares $868.35 million +1.3%1.7%2.3 $86.06 1/31/20249,960,000 shares $781.56 million -8.4%1.7%2.2 $78.47 1/15/202410,870,000 shares $804.71 million +2.0%1.8%2.4 $74.03 12/31/202310,660,000 shares $812.83 million -21.3%1.8%2.3 $76.25 12/15/202313,540,000 shares $1.04 billion +34.7%2.3%2.8 $76.90 11/30/202310,050,000 shares $680.49 million -6.5%1.7%2.3 $67.71 11/15/202310,750,000 shares $720.36 million -6.3%1.8%2.6 $67.01 10/31/202311,470,000 shares $730.87 million -1.1%1.9%2.9 $63.72 10/15/202311,600,000 shares $821.05 million -13.4%1.9%3.1 $70.78 9/30/202313,400,000 shares $928.35 million +5.5%2.2%3.8 $69.28 9/15/202312,700,000 shares $929.64 million +18.1%2.1%4 $73.20 8/31/202310,750,000 shares $822.05 million +13.0%1.8%3.4 $76.47 8/15/20239,510,000 shares $759.47 million +0.4%1.6%3 $79.86 7/31/20239,470,000 shares $777.20 million -2.9%1.6%3.3 $82.07 7/15/20239,750,000 shares $910.46 million -0.9%1.6%3.7 $93.38 6/30/20239,840,000 shares $928.21 million -4.4%1.6%3.7 $94.33 6/15/202310,290,000 shares $939.37 million -7.4%1.7%3.8 $91.29 5/31/202311,110,000 shares $935.91 million +12.9%1.9%3.9 $84.24 5/15/20239,840,000 shares $874.97 million +7.2%1.6%3.2 $88.92 4/30/20239,180,000 shares $807.66 million -27.3%1.5%2.8 $87.98 4/15/202312,620,000 shares $1.06 billion -10.1%2.1%3.6 $84.36Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 3/31/202314,040,000 shares $1.16 billion -17.1%2.3%4.1 $82.73 3/15/202316,940,000 shares $1.35 billion +32.7%2.8%4.7 $79.48 2/28/202312,770,000 shares $1.03 billion +6.8%2.1%3.2 $80.44 2/15/202311,960,000 shares $931.92 million -12.4%2.0%3 $77.92 1/31/202313,650,000 shares $1.05 billion -2.0%2.2%3 $76.70 1/15/202313,930,000 shares $1.09 billion -9.2%2.3%2.7 $78.31 12/30/202215,340,000 shares $1.14 billion +9.9%2.5%3 $74.61 12/15/202213,960,000 shares $1.03 billion +27.0%2.3%2.8 $73.55 11/30/202210,990,000 shares $848.98 million +4.0%1.8%2.3 $77.25 11/15/202210,570,000 shares $802.90 million +30.3%1.7%2.5 $75.96 10/31/20228,110,000 shares $587.41 million +8.9%1.3%2.2 $72.43 10/15/20227,450,000 shares $614.03 million -1.7%1.2%2.7 $82.42 9/30/20227,580,000 shares $626.34 million +15.9%1.2%3 $82.63 9/15/20226,540,000 shares $620.52 million +77.7%1.1%2.5 $94.88 8/31/20223,680,000 shares $331.57 million -27.0%0.6%1.4 $90.10 8/15/20225,040,000 shares $527.89 million -9.0%0.8%2 $104.74 7/31/20225,540,000 shares $556.99 million -16.8%0.9%2.1 $100.54 7/15/20226,660,000 shares $662.20 million +7.3%1.1%2.4 $99.43 6/30/20226,210,000 shares $590.51 million +5.8%1.0%2.2 $95.09 6/15/20225,870,000 shares $521.14 million -10.5%2.9%2 $88.78 5/31/20226,560,000 shares $661.58 million +27.4%1.1%2.3 $100.85 5/15/20225,150,000 shares $502.38 million +6.0%0.8%1.9 $97.55 4/30/20224,860,000 shares $514.09 million -15.2%0.8%1.8 $105.78 4/15/20225,730,000 shares $687.71 million +28.5%0.9%2.1 $120.02 3/31/20224,460,000 shares $525.03 million No Change0.7%1.7 $117.72 3/15/20224,460,000 shares $473.43 million -20.6%0.7%1.7 $106.15 2/28/20225,620,000 shares $631.52 million -11.1%0.9%2.1 $112.37 2/15/20226,320,000 shares $701.08 million +9.5%1.0%2.3 $110.93 1/31/20225,770,000 shares $630.08 million +6.5%0.9%2.2 $109.20 1/15/20225,420,000 shares $640.97 million -10.9%0.9%2.2 $118.26 12/31/20216,080,000 shares $787.66 million +10.0%1.0%2.6 $129.55 12/15/20215,530,000 shares $663.10 million -3.8%0.9%2.2 $119.91 11/30/20215,750,000 shares $617.03 million +4.0%0.9%2.5 $107.31 11/15/20215,530,000 shares $645.30 million -20.2%0.9%2.6 $116.69 10/29/20216,930,000 shares $830.35 million +6.0%1.1%3.3 $119.82 10/15/20216,540,000 shares $733.53 million +7.6%1.1%3.2 $112.16 9/30/20216,080,000 shares $688.32 million +2.7%1.0%2.8 $113.21 9/15/20215,920,000 shares $716.44 million -2.0%1.0%2.8 $121.02 8/31/20216,040,000 shares $707.77 million +0.8%1.0%2.8 $117.18 8/13/20215,990,000 shares $677.77 million -1.3%1.0%2.6 $113.15 7/30/20216,070,000 shares $681.48 million -8.9%1.0%2.6 $112.27 7/15/20216,660,000 shares $708.22 million +20.4%1.1%2.8 $106.34 6/30/20215,530,000 shares $572.74 million -9.1%0.9%2.2 $103.57 6/15/20216,080,000 shares $609.70 million +4.5%1.0%2.4 $100.28 5/28/20215,820,000 shares $558.14 million -2.8%0.9%2.3 $95.90 5/14/20215,990,000 shares $526.76 million -13.4%N/A2.2 $87.94 4/30/20216,920,000 shares $666.12 million +5.2%N/A2.5 $96.26 4/15/20216,580,000 shares $567.53 million +24.6%N/A2.3 $86.25 3/31/20215,280,000 shares $437.45 million -2.6%N/A2 $82.85 3/15/20215,420,000 shares $444.82 million -3.0%N/A2.1 $82.07Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 2/26/20215,590,000 shares $469.39 million -17.1%N/A2.2 $83.97 2/12/20216,740,000 shares $593.59 million +50.8%N/A2.8 $88.07 1/29/20214,470,000 shares $372.71 million +3.5%N/A1.8 $83.38 1/15/20214,320,000 shares $377.96 million -6.9%N/A1.7 $87.49 12/31/20204,640,000 shares $415.93 million -5.7%N/A1.9 $89.64 12/15/20204,920,000 shares $411.16 million -7.5%N/A2 $83.57 11/30/20205,320,000 shares $453.58 million +6.0%N/A2.1 $85.26 11/15/20205,020,000 shares $410.54 million +0.8%N/A1.9 $81.78 10/30/20204,980,000 shares $363.09 million -29.7%N/A2 $72.91 10/15/20207,080,000 shares $603.00 million +5.8%N/A3 $85.17 9/30/20206,690,000 shares $534.00 million -2.8%N/A2.6 $79.82 9/15/20206,880,000 shares $573.10 million -5.0%N/A2.6 $83.30 8/31/20207,240,000 shares $621.48 million +15.7%N/A2.7 $85.84 8/14/20206,260,000 shares $488.72 million -3.4%N/A2.2 $78.07 7/31/20206,480,000 shares $508.10 million -12.0%N/A2.2 $78.41 7/15/20207,360,000 shares $524.18 million -7.1%N/A2.3 $71.22 6/30/20207,920,000 shares $537.69 million +8.9%N/A2.4 $67.89 6/15/20207,270,000 shares $501.34 million +206.8%N/A1.9 $68.96 5/29/20202,370,000 shares $532.59 million -4.1%N/A0.5 $224.72 5/15/20202,470,000 shares $175.34 million +3.8%1.2%1.5 $70.99 4/30/20202,380,000 shares $172.55 million -4.0%1.2%1.4 $72.50 4/15/20202,480,000 shares $177.44 million -18.7%1.2%1.4 $71.55 3/31/20203,050,000 shares $681.61 million +31.3%1.5%1.7 $223.48 3/13/20202,322,900 shares $500.45 million +7.5%1.1%1.6 $215.44 2/28/20202,160,000 shares $339.62 million +4.4%1.0%1.4 $157.23 2/14/20202,070,000 shares $419.94 million +1.5%1.0%1.6 $202.87 1/31/20202,040,000 shares $452.02 million -14.3%1.0%1.6 $221.58 1/15/20202,380,000 shares $550.14 million +1.3%1.2%1.9 $231.15 12/31/20192,350,000 shares $541.56 million +18.7%1.1%2 $230.45 EW Short Interest - Frequently Asked Questions What is Edwards Lifesciences' current short interest? Short interest is the volume of Edwards Lifesciences shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 8,580,000 shares of EW short. 1.48% of Edwards Lifesciences' shares are currently sold short. Learn More on Edwards Lifesciences' current short interest. What is a good short interest ratio for Edwards Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EW shares currently have a short interest ratio of 2.0. Learn More on Edwards Lifesciences's short interest ratio. Which institutional investors are shorting Edwards Lifesciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Edwards Lifesciences: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Paloma Partners Management Co, Garda Capital Partners LP, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., SpiderRock Advisors LLC, Genus Capital Management Inc., Caas Capital Management LP, Wealth Enhancement Advisory Services LLC, and SG Americas Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Edwards Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.48% of Edwards Lifesciences' floating shares are currently sold short. Is Edwards Lifesciences' short interest increasing or decreasing? Edwards Lifesciences saw a increase in short interest in November. As of November 30th, there was short interest totaling 8,580,000 shares, an increase of 24.9% from the previous total of 6,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edwards Lifesciences' float size? Edwards Lifesciences currently has issued a total of 589,800,000 shares. Some of Edwards Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edwards Lifesciences currently has a public float of 579,780,000 shares. How does Edwards Lifesciences' short interest compare to its competitors? 1.48% of Edwards Lifesciences' shares are currently sold short. Here is how the short interest of companies compare to Edwards Lifesciences: Stryker Co. (1.19%), Boston Scientific Co. (0.83%), Medtronic plc (0.78%), Becton, Dickinson and Company (0.66%), IDEXX Laboratories, Inc. (1.48%), ResMed Inc. (5.14%), DexCom, Inc. (2.16%), STERIS plc (0.95%), Insulet Co. (4.35%), Hologic, Inc. (2.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Edwards Lifesciences stock? Short selling EW is an investing strategy that aims to generate trading profit from Edwards Lifesciences as its price is falling. EW shares are trading up $1.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edwards Lifesciences? A short squeeze for Edwards Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EW, which in turn drives the price of the stock up even further. How often is Edwards Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EW, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies SYK Short Squeeze BSX Short Squeeze MDT Short Squeeze BDX Short Squeeze IDXX Short Squeeze RMD Short Squeeze DXCM Short Squeeze STE Short Squeeze PODD Short Squeeze HOLX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EW) was last updated on 12/20/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
